Evaluation of whole-body tumor burden with 68Ga-PSMA PET/CT in the biochemical recurrence of prostate cancer

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Ronald Boellaard, Roberto C. Delgado Bolton, Wim J.G. Oyen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 3.3K citations · Full text

Medicine, Nuclear Medicine, Radiology +17

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

Philip Cornford, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 1.4K citations

Medicine, Oncology, Urology +17

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci et al. · Journal of Clinical Oncology · 2018 · 1.1K citations · Full text

Medicine, Oncology, Urology +17

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

Frederik L. Giesel, Boris Hadaschik, Jens Cardinale et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 602 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis

Chia-Hung Lin, Emmanuel Itti, Corinne Haïoun et al. · Journal of Nuclear Medicine · 2007 · 396 citations · Full text

Medicine, Nuclear Medicine, Oncology +17